Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013Paz Sobrino‐Vegas, Almudena García Torre, Santiago Moreno et al.|Journal of Infection|2016Cited by 89
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.R. Arranz, J M Fernández-Rañada, C Rayón et al.|Journal of Clinical Oncology|1998Cited by 56
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret May, Jonathan A C Sterne, Robert S. Hogg et al.|International Journal of Epidemiology|2012Cited by 39
Relationship between plasma bilirubin level and oxidative stress markers in <scp>HIV</scp>‐infected patients on atazanavir‐ <i>vs</i>. efavirenz‐based antiretroviral therapyVicente Estrada, José Ramón Blanco, Susana Monge et al.|HIV Medicine|2016Cited by 23
Comparison of oxidative stress markers in HIV‐infected patients on efavirenz or atazanavir/ritonavir‐based therapyVicente Estrada, José Ramón Blanco, Susana Monge et al.|Journal of the International AIDS Society|2014Cited by 11